H. Bechtold

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus

Pharmacology and Management of the Vitamin K Antagonists

Arrhythmias and mortality in congestive heart failure

Estrogen Receptors: How Do They Signal and What Are Their Targets

Sudden death in idiopathic dilated cardiomyopathy

Prenylation inhibitors: a novel class of antiviral agents

The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: A dangerous imbalance in the risk-benefit ratio

ARRHYTHMIA IN HEART FAILURE: ROLE OF MECHANICALLY INDUCED CHANGES IN ELECTROPHYSIOLOGY

Cardiac failure and sudden death in the Framingham Study

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Oral Anticoagulant Therapy

Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of fallot

Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

Unequal Atrial Stretch in dogs Increases Dispersion of Refractoriness Conducive to developing Atrial Fibrillation

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy.

Intraventricular conduction delay: a prognostic marker in chronic heart failure

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

The role of implantable cardioverter defibrillators in dilated cardiomyopathy

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?

Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy

Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Antithrombotic Therapy for VTE Disease

A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan

Chemotherapy and the war on cancer

Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study

Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia

Cardiac Resynchronization in Chronic Heart Failure

The Clinical Course of Pulmonary Embolism

Targeting RAS signalling pathways in cancer therapy

Myocarditis

Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure

Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure

Novel estrogen receptor coregulators and signaling molecules in human diseases

Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction Delay

Oral Anticoagulants

Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults

Task Force on Sudden Cardiac Death of the European Society of Cardiology

Relation Between Gender, Etiology and Survival in Patients With Symptomatic Heart Failure

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT

Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy

The Pharmacology and Management of the Vitamin K Antagonists

Predicting Mortality Among Patients Hospitalized for Heart Failure

Nonsustained Ventricular Tachycardia

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

High-dose nitrates in the immediate management of unstable angina: Optimal dosage, route of administration, and therapeutic goals

Mortality in heart failure: clinical variables of prognostic value.

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Survival of patients with severe congestive heart failure treated with oral milrinone

Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication

Electrophysiological effects of acute ventricular dilatation in the isolated rabbit heart.

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

Nonreentrant Mechanisms Underlying Spontaneous Ventricular Arrhythmias in a Model of Nonischemic Heart Failure in Rabbits

Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy

Plasma disposition of vitamin K1 in relation to anticoagulant poisoning.

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice

A Prenylation Inhibitor Prevents Production of Infectious Hepatitis Delta Virus Particles

A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells

Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure

Atrial Fibrillation Begets Atrial Fibrillation

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication

Concepts in Ras-directed therapy

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

Interferon-Stimulated Genes: A Complex Web of Host Defenses

Sudden Cardiac Death

Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure: Basis of a new physiologic approach to control of arrhythmia

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Use of a Prenylation Inhibitor as a Novel Antiviral Agent

Nuclear Lamins a and B1

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one-hour ambulatory electrocardiographic monitoring

Holter monitoring in Chagas' heart disease

Risk of ventricular arrhythmias in left ventricular hypertrophy: The Framingham Heart Study

Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation

Molecular Mechanisms of Myocardial Remodeling

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Part 8: Adult Advanced Cardiovascular Life Support

Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes

Behind the Curtain of Pericardial Tamponade: Cardiac Hemangioendotheliosarcoma

Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin�) in atrial fibrillation and TEE-guided cardioversion

Cyclic interconversion of vitamin K1 and vitamin K1 2,3‐epoxide in man.

Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina

The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization.

Evidence for Impaired Hepatic Vitamin K1 Metabolism in Patients Treated with N-Methyl-Thiotetrazole Cephalosporins

Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy